PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Jan-2025 Invitation to Straumann Group’s FYR 2024 analysts and media conference at Straumann Group Headquarters Straumann Holding AG
27-Jan-2025 Invitation to Straumann Group’s 2024 full-year results webcast Straumann Holding AG
27-Jan-2025 CapeStart Closes 2024 with New Clients, Strategic Hires and Launch of MadeAi CapeStart
27-Jan-2025 Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements Mainz BioMed N.V.
27-Jan-2025 Progress in the MDR process - aap receives MDR certificate aap Implantate AG
27-Jan-2025 Powder Testing Workstation™ PTW and Powder Testing Assistant™ PTA 100i Copley Scientific
27-Jan-2025 GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency GSK
27-Jan-2025 Clinigen Announces Strategic Partnership with Tepsivo Clinigen
27-Jan-2025 HCA to invest US$4 million in Ondine Ondine Biomedical Inc
27-Jan-2025 Reithera and Sillajen Partnership Announced Reithera
27-Jan-2025 CPHI Americas 2025 to Strengthen Pharma Industry and Economic Ties Across the Region CPHI Americas 2025
27-Jan-2025 DS SMITH LAUNCHES TAILORTEMP® AT PHARMAPACK EUROPE 2025 DS SMITH
27-Jan-2025 Olink® Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology Thermo Fisher Scientific
27-Jan-2025 Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD) Roche
27-Jan-2025 Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy... Bristol Myers Squibb
27-Jan-2025 Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer Pfizer
27-Jan-2025 GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency GSK
27-Jan-2025 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
24-Jan-2025 Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million Pentixapharm Holding AG
24-Jan-2025 ELRIG Announces Drs Jue Wang and Robert Grundy as Keynote Speakers at Research & Innovation 2025 ELRIG